1,672
Views
4
CrossRef citations to date
0
Altmetric
Research Article

High intensity focused ultrasound treatment for diffuse uterine leiomyomatosis: a feasibility study

, , , , , , & show all
Pages 1060-1065 | Received 30 Apr 2020, Accepted 22 Aug 2020, Published online: 07 Sep 2020

References

  • Thomas EO, Gordon J, Smith-Thomas S, et al. Diffuse uterine leiomyomatosis with uterine rupture and benign metastatic lesions of the bone. Obstet Gynecol. 2007;109(2 Pt2):528–530.
  • Fedele L, Zamberletti D, Carinelli S, et al. Diffuse uterine leiomyomatosis. Acta Eur Fertil. 1982;13(3):125–131.
  • Clement PB, Young RH. Diffuse leiomyomatosis of the uterus: a report of four cases. Int J Gynecol Pathol. 1987;6(4):322–330.
  • Mulvany NJ, Ostor AG, Ross I. Diffuse leiomyomatosis of the uterus. Histopathology. 1995;27(2):175–179.
  • Fedele L, Bianchi S, Zanconato G, et al. Conservative treatment of diffuse uterine leiomyomatosis. Fertil Steril. 2004;82(2):450–453.
  • Coskun A, Ozdemir O, Vardar MA, et al. A case with diffuse uterine leiomyomatosis and review of the literature. Clin Exp Obstet Gynecol. 2008;35(3):227–230.
  • Baschinsky DY, Isa A, Niemann TH, et al. Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Pathol. 2000;31(11):1429–1432.
  • Chen L, Xiao X, Wang Q, et al. High-intensity focused ultrasound ablation for diffuse uterine leiomyomatosis: A case report. Ultrason Sonochem. 2015;27:717–721.
  • Yang X, Zhang X, Lin B, et al. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. Int J Hyperthermia. 2019;36(1):486–492.
  • Shui L, Mao S, Wu Q, et al. High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results. Ultrason Sonochem. 2015;27:677–681.
  • Scheurig C, Islam T, Zimmermann E, et al. Uterine artery embolization in patients with symptomatic diffuse leiomyomatosis of the uterus. J Vascular Interventional Radiol. 2008;19(2):279–284.
  • Nishida M, Ichikawa R, Arai Y, et al. New myomectomy technique for diffuse uterine leiomyomatosis. J Obstet Gynaecol Res. 2014;40(6):1689–1694.
  • Yen CF, Lee CL, Wang CJ, et al. Successful pregnancies in women with diffuse uterine leiomyomatosis after hysteroscopic management. Fertil Steril. 2007;88(6):1667–1673.
  • Zhao H, Yang B, Li H, et al. Successful Pregnancies in Women with Diffuse Uterine Leiomyomatosis after Hysteroscopic Management Using the Hysteroscopy Endo Operative System. J Minim Invasive Gynecol. 2019;26(5):960–967.
  • Koh J, Kim MD, Jung DC, et al. Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus: clinical and imaging results. Eur J Radiol. 2012;81(10):2726–2729.
  • Lefebvre G, Vilos G, Allaire C, et al. The management of uterine leiomyomas. J Obstetr Gynaecol Canada 2003;25(5):396–418.
  • Zhang Y, Sun L, Guo Y, et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis. Obstet Gynecol Surv. 2014;69(2):100–108.
  • Sankaran S, Manyonda IT. Medical management of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):655–676.
  • Liu X, Xue L, Wang Y, et al. Vaginal delivery outcomes of pregnancies following ultrasound-guided high-intensity focused ultrasound ablation treatment for uterine fibroids. Int J Hyperthermia. 2018;35(1):510–517.
  • Ji Y, Hu K, Zhang Y, et al. High-intensity focused ultrasound (HIFU) treatment for uterine fibroids: a meta-analysis. Arch Gynecol Obstet. 2017;296(6):1181–1188.